Literature DB >> 24141089

F(ab')2 fragment of a gp41 NHR-trimer-induced IgM monoclonal antibody neutralizes HIV-1 infection and blocks viral fusion by targeting the conserved gp41 pocket.

Lu Lu1, Meili Wei, Yanxia Chen, Weiliang Xiong, Fei Yu, Zhi Qi, Shibo Jiang, Chungen Pan.   

Abstract

Using a recombinant protein N46FdFc that mimics the HIV-1 gp41 N-helix trimer to immunize mice, we identified the first IgM monoclonal antibody 18D3 that specifically bound to the conserved gp41 pocket. Its F(ab')2 fragment potently inhibited HIV-1 Env-mediated cell-cell fusion and neutralized infection by laboratory-adapted and primary HIV-1 isolates with different subtypes and tropism, including the T20-resistant variants. This F(ab')2 fragment can be used to develop a bispecific broad neutralizing monoclonal antibody or HIV-1 inactivator as a novel immunotherapeutic for treatment and prevention of HIV-1 infection.
Copyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  HIV fusion inhibitor; HIV-1; Immunotherapeutics; Monoclonal antibody; gp41

Mesh:

Substances:

Year:  2013        PMID: 24141089     DOI: 10.1016/j.micinf.2013.10.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

Review 1.  Receptor binding domain based HIV vaccines.

Authors:  Huan Liu; Wenwen Bi; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

2.  A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.

Authors:  Adonis A Rubio; Maria V Filsinger Interrante; Benjamin N Bell; Clayton L Brown; Theodora U J Bruun; Celia C LaBranche; David C Montefiori; Peter S Kim
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.